What's the next innovation in Oncology?
Investment in Oncology is strong but dynamic: In 2016, major deals facilitated big moves in the Hot Indications list. One focus was immuno-oncology combinations, which have driven collaboration between big pharma and biotech.This Deep Dive includes:
- Update on the top indications within Oncology
- Analysis of the biggest movers and losers within Oncology
- Insights on acquisitions, drug approvals, and pipeline activity
Complete the form to download our Oncology Deep Dive.